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Letter to the Editor

Conservative management of patients with endometrial intraepithelial neoplasia (EIN):
Factors that could affect response and pregnancy rates.
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Dear Editor,
With a great deal of interest, we read your article entitled
“Outcomes of the conservative management of the patients
with endometrial intraepithelial neoplasia/endometrial
cancer: Wait or treat! by Işçi Bostanci et al. [1].
This is a retrospective study presenting the conservative
management of 38 patients with either endometrial cancer
(EC) (6/38) or endometrial intraepithelial neoplasia (EIN)
(31/38) with progestins (such as medroxyprogesterone
acetate, megestrol acetate, or levonorgestrel-releasing
intrauterine device) and follow-up endometrial biopsies
every 3–6 months.
We would like to focus on the results of the 32 patients
with EIN. The majority of them (28/32– 87.5%) had a
response while 8 (25%) had a relapse and 4 (12.5%) had
persistent disease. Seven pregnancies were achieved with
five live births, and all of the pregnancies were seen in
the EIN group [1]. One patient with EIN progressed to
advanced endometrioid carcinoma [1].
Recently, Cordeiro Mitchell et al. published a similar
retrospective study, which revealed that among 54 patients
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who were conservatively treated for EC/EIN, nearly 20%
developed intrauterine synechiae [2]. We would like to ask
the authors if they can provide us with the intrauterine
synechiae rates in their retrospective study and inform
us whether there might be a correlation with the lower
pregnancy rates in their series.
Another group showed the addition of metformin to
progestin therapy could have little impact on response
rates and lower live-birth rates [3]. We would like to ask the
authors if they have any experience with the combination
of metformin and progestin in their cohort.
Finally, Rafone et al. in a systematic review and metaanalysis stated that diabetes mellitus does not affect
the responsiveness of such pathology to conservative
treatment [4]. As the BMI of the Turkish patients is quite
high, we would like to ask the authors to further inform us
if they found any correlation with diabetes mellitus either
for disease progression or fertility outcome.
Once again, we would like to thank the authors for their
excellent work, and we would appreciate it if they could
present any of these requested data if they are available.
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